Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

An overview of how on-call consultant paediatricians can recognise and manage severe primary immunodeficiencies.

Wekell P, Hertting O, Holmgren D, Fasth A.

Acta Paediatr. 2019 Dec;108(12):2175-2185. doi: 10.1111/apa.14930. Epub 2019 Aug 23.

PMID:
31278775
2.

Serious complications due to acute rhinosinusitis in children up to five years old in Stockholm, Sweden - Still a challenge in the pneumococcal conjugate vaccine era.

Dennison SH, Ask LS, Eriksson M, Granath A, Hertting O, Bennet R, Lindstrand A, Masaba P, Dimitriou P, Stjärne P.

Int J Pediatr Otorhinolaryngol. 2019 Jun;121:50-54. doi: 10.1016/j.ijporl.2019.02.034. Epub 2019 Feb 25.

PMID:
30861428
3.

Fifteen-minute consultation: Recognising primary immune deficiencies in children.

Wekell P, Hertting O, Holmgren D, Fasth A.

Arch Dis Child Educ Pract Ed. 2019 Oct;104(5):235-243. doi: 10.1136/archdischild-2018-315484. Epub 2019 Feb 7.

PMID:
30733240
4.

Vitamin D-deficient mice have more invasive urinary tract infection.

Hertting O, Lüthje P, Sullivan D, Aspenström P, Brauner A.

PLoS One. 2017 Jul 27;12(7):e0180810. doi: 10.1371/journal.pone.0180810. eCollection 2017.

5.

An infant with Klebsiella oxytoca septic arthritis.

Hertting O, Gremark O, Källman O, Guler L, Bergström J.

J Microbiol Immunol Infect. 2018 Feb;51(1):153-154. doi: 10.1016/j.jmii.2016.12.011. Epub 2017 Jun 29. No abstract available.

6.

Antibiotic use during infectious episodes in the first 6 months of anticancer treatment-A Swedish cohort study of children aged 7-16 years.

Af Sandeberg M, Johansson E, Wettergren L, Björk O, Hertting O, Nilsson A.

Pediatr Blood Cancer. 2017 Jul;64(7). doi: 10.1002/pbc.26397. Epub 2017 Jan 11.

PMID:
28074531
7.

Childhood TB: when to think of it and what to do when you do.

Hertting O, Shingadia D.

J Infect. 2014 Jan;68 Suppl 1:S151-4. doi: 10.1016/j.jinf.2013.09.025. Epub 2013 Oct 9. Review.

PMID:
24119929
8.

Vitamin D induction of the human antimicrobial Peptide cathelicidin in the urinary bladder.

Hertting O, Holm Å, Lüthje P, Brauner H, Dyrdak R, Jonasson AF, Wiklund P, Chromek M, Brauner A.

PLoS One. 2010 Dec 14;5(12):e15580. doi: 10.1371/journal.pone.0015580.

9.

Cytotoxic necrotizing factor 1 (CNF1) induces an inflammatory response in the urinary tract in vitro but not in vivo.

Hertting O, Chromek M, Slamová Z, Kádas L, Söderkvist M, Vainumäe I, Tallvik T, Jacobson SH, Brauner A.

Toxicon. 2008 Jun 15;51(8):1544-7. doi: 10.1016/j.toxicon.2008.03.019. Epub 2008 Mar 26.

PMID:
18471840
10.

CAPD peritonitis induces the production of a novel peptide, daintain/allograft inflammatory factor-1.

Brauner A, Hertting O, Alkstrand E, Sandberg E, Chromek M, Chen ZW, Ostenson CG.

Perit Dial Int. 2003 Jan-Feb;23(1):5-13.

PMID:
12691501
11.

Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinases-1 in acute pyelonephritis and renal scarring.

Chromek M, Tullus K, Hertting O, Jaremko G, Khalil A, Li YH, Brauner A.

Pediatr Res. 2003 Apr;53(4):698-705. Epub 2003 Feb 20.

PMID:
12612199
12.

Enhanced chemokine response in experimental acute Escherichia coli pyelonephritis in IL-1beta-deficient mice.

Hertting O, Khalil A, Jaremko G, Chromek M, Li YH, Bakhiet M, Bartfai T, Tullus K, Brauner A.

Clin Exp Immunol. 2003 Feb;131(2):225-33.

Supplemental Content

Loading ...
Support Center